(RTTNews) - EyePoint Pharmaceuticals, Inc. (EYPT), Wednesday announced positive six-month results from the ongoing Phase 2 VERONA clinical trial, evaluating Duravyu for the treatment of diabetic ...

I’ve said this before: I’m no eye-cream evangelist. I’m a firm believer that your regular moisturizer should work just fine for the skin under your eyes as long as it isn’t too heavy and ...

Investing.com -- Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: NASDAQ:EYPT) fell 21% today, diverging from the company's recent announcement of positive results from the Phase 2 VERONA ...

Showcase your company news with guaranteed exposure both in print and online 25 years ago, Denver's economy thrived on IT, real estate & oil. DBJ will kick… Be Inspired! Meet Your Mentor! Make ...

In a bid to complement the efforts of the Ministry of Health (MOH), Mbolo Association, a charity organisation in collaboration with the opticians and eye specialists of Martravisions Optica based in ...

Eye­Point Phar­ma­ceu­ti­cals, a biotech at­tempt­ing to grab a sliv­er of Re­gen­eron’s share of the de­gen­er­a­tive eye dis­ease mar­ket, said six-month re­sults show its ...

January 31, 2025 • Beyonce says she's always been country. Now, with "Cowboy Carter," she's nominated for 11 Grammys and the first Black woman to top country music charts. How Beyonce fits into ...

After hours: February 7 at 5:53:30 PM EST Loading Chart for BOLT ...

Sky News host Andrew Bolt says the free speech of Australians is being affected by politicians failing to do their job.

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate EyePoint Pharmaceuticals, Inc. before investing. In this article, we go over a ...